Loading current evidence…
Public records only. Your private brief and follow-up notes are not included.
Ask what this evidence establishes, what remains open, or what to check next.
Sector radar / Pharmaceuticals
Sector brief: what Chinese policy is doing in this sector, how it treats foreign firms, who is named, and what China sells abroad. Every figure links to its documents. Goods: Biologics and vaccines (3002), dosed medicines (3004).
Next five years: named in 14 of the 15 15th Five-Year Plan outlines held (11.5 mentions per 100k characters), against 7 of 7 14th-plan outlines (10.4): 1.1× as dense; up in 2 and down in 2 of the 4 places with both. Sanming: “搭建医药CMO、CDMO专业化服务平台，吸引上下游配套企业集聚，培育特色医药产业集群。” (outline)
Central plan: 工业和信息化部等十部门关于印发《医药工业发展“十五五”规划》的通知 (2026-08-28); no provincial restatement held yet; provinces have restated this sector's earlier central documents 179–311 days after them (quartiles), so the typical province's restatement falls Feb 2027 – Jul 2027; the first can come much sooner. Plan watch.
Documents held, so collection shapes the curve; the momentum ratio is relative to the corpus.
| Heading | world | growth/yr | EU-27 | EU since 2023 | share of EU imports |
|---|---|---|---|---|---|
| Vaccines and biologics 3002 | $1.2bn | 9% | $267m | 104% | 1% |
| Dosed medicines 3004 | $8.0bn | 13% | $3.5bn | 125% | 7% |
EU price and volume: imports from China €354.58/kg against €367.22/kg from other suppliers in 2025 (-3%; -61% in 2023). Volume since 2023: China 25%, others 3%.
| Date | Central document | provinces | median lag | |
|---|---|---|---|---|
| 2024-12-30 | 国务院办公厅关于全面深化药品医疗器械监管改革促进医药产业高质量发展的意见 Opinions of the General Office of the State Council on Comprehensively Deepening Reforms in the Regulation of… 国办发〔2024〕53号 |
8 | 297 d | trace → |
| 2021-01-22 | 国务院办公厅关于推动药品集中带量采购工作常态化制度化开展的意见 Opinions of the General Office of the State Council on Promoting the Regularised and Institutionalised Implem… 国办发〔2021〕2号 |
4 | 1662 d | trace → |
| 2025-12-05 | 国家医保局 人力资源社会保障部关于印发《国家基本医疗保险、生育保险和工伤保险药品目录》以及《商业健康保险创新药品目录》（2025年）的通知 Notice from the National Healthcare Security Administration and the Ministry of Human Resources and Social Se… 医保发〔2025〕33号 |
4 | 21 d | trace → |
| 2025-03-15 | 国务院办公厅关于提升中药质量促进中医药产业高质量发展的意见 Opinions of the General Office of the State Council on Improving the Quality of Traditional Chinese Medicine … 国办发〔2025〕11号 |
3 | 163 d | trace → |
| 2025-06-30 | 国家医保局 国家卫生健康委关于印发《支持创新药高质量发展的若干措施》的通知 Notice from the National Medical Insurance Administration and the National Health Commission on the Issuance … 医保发〔2025〕16号 |
1 | 179 d | trace → |
| 2025-04-03 | 工业和信息化部等七部门关于印发《医药工业数智化转型实施方案（2025—2030年）》的通知 Notice from the Ministry of Industry and Information Technology and Six Other Departments on the Issuance of … 工信部联消费〔2025〕79号 |
1 | 565 d | trace → |
| 2021-12-22 | 关于印发“十四五”医药工业发展规划的通知 Notice on the Issuance of the ‘14th Five-Year Plan’ for the Development of the Pharmaceutical Industry 工信部联规〔2021〕217号 |
1 | 1024 d | trace → |
| 2021-10-29 | 国家发展改革委 工业和信息化部关于推动原料药产业高质量发展实施方案的通知 Notice from the National Development and Reform Commission and the Ministry of Industry and Information Techn… 发改产业〔2021〕1523号 |
1 | 311 d | trace → |
Across all State Council directives the median lag to a province's implementing document is about 151 days (middle half 84–259).
| Province | documents (36 m) | leans | with money | favouring | local-only programmes | |
|---|---|---|---|---|---|---|
| Shanghai | 24 | ×2.7 | 5 | 5 | 15% of 620 | exposure → |
| Hubei | 7 | ×2.0 | 1 | 1 | 7% of 266 | exposure → |
| Shandong | 5 | ×2.7 | 0 | 0 | 4% of 169 | exposure → |
| Beijing | 4 | ×0.9 | 0 | 2 | 13% of 100 | exposure → |
| Sichuan | 4 | ×0.8 | 1 | 0 | 8% of 451 | exposure → |
| Chongqing | 3 | ×1.5 | 1 | 0 | 0% of 67 | exposure → |
| Guizhou | 3 | ×1.9 | 1 | 0 | 1% of 209 | exposure → |
| Fujian | 2 | – | 2 | 0 | 2% of 199 | exposure → |
| Anhui | 2 | – | 1 | 0 | 0% of 26 | exposure → |
| Jiangsu | 2 | – | 0 | 0 | 6% of 141 | exposure → |
| Tianjin | 2 | – | 1 | 1 | 0% of 9 | exposure → |
| Jiangxi | 2 | – | 1 | 0 | 5% of 111 | exposure → |
| 2026-08-28 | 工业和信息化部等十部门关于印发《医药工业发展“十五五”规划》的通知 Notice from the Ministry of Industry and Information Technology and Nine Other Departments on the Issuance of… 工信部联规〔2026〕210号 |
| 2026-03-20 | 国家药监局关于印发药品现代物流规范化建设指导意见的通知 Notice of the National Medical Products Administration on the Issuance of the Guidelines on the Standardisati… 国药监药管〔2026〕7号 |
| 2026-03-11 | 国家药监局关于“人工智能+药品监管”的实施意见 Implementation Guidelines of the National Medical Products Administration on ‘Artificial Intelligence and Med… 国药监综〔2026〕6号 |
| 2025-12-08 | 关于印发第四批鼓励仿制药品目录的通知 Notice on the Issuance of the Fourth Batch of the Catalogue of Medicines Encouraged for Generic Production 国卫办药政函〔2025〕483号 |
| 2025-12-05 | 国家医保局 人力资源社会保障部关于印发《国家基本医疗保险、生育保险和工伤保险药品目录》以及《商业健康保险创新药品目录》（2025年）的通知 Notice from the National Healthcare Security Administration and the Ministry of Human Resources and Social Se… 医保发〔2025〕33号 |
| 2025-08-18 | 国务院关于《中国（江苏）自由贸易试验区生物医药全产业链开放创新发展方案》的批复 Approval by the State Council of the ‘Plan for Open and Innovative Development of the Full Biopharmaceutical … 国函〔2025〕80号 |
| 2025-07-10 | 国家医疗保障局关于公布《2025年国家基本医疗保险、生育保险和工伤保险药品目录及商业健康保险创新药品目录调整工作方案》等相关文件的公告 Announcement by the National Healthcare Security Administration on the Publication of the ‘Work Plan for the … |
| 2025-06-30 | 国家医保局 国家卫生健康委关于印发《支持创新药高质量发展的若干措施》的通知 Notice from the National Medical Insurance Administration and the National Health Commission on the Issuance … 医保发〔2025〕16号 |
| 2026-10-20 | 贵州省健康医药产业高质量发展实施方案（2026-2030年）（征求意见 Implementation Plan for the High-Quality Development of the Health and Pharmaceutical Industry in Guizhou Pro… Guizhou Provincial People's Government |
| 2026-08-31 | 关于取消个别企业中选资格并列入违规名单的公告 announcement · 山东省全国中药饮片联盟采购办公室 |
| 2026-08-18 | 关于公开征求《山东省医药工业“十五五”发展行动方案（征求意见稿）》意见的公告 announcement · Shandong Provincial Department of Industry and Information Technology |
| 2026-07-30 | 北京市药品监督管理局等单位关于印发《北京市生物医药研发用物品进口工作方案》的通知 Notice from the Beijing Municipal Drug Administration and Other Organisations on the Issuance of the ‘Work Pl… 北京市药品监督管理局 北京市经济和信息化局;北京市科学技术委员会、中关村科技园区管理委员会;北京市商务局 |
| 2026-06-23 | 关于印发《关于支持生物医药外资企业高能级项目落地的若干措施》的通知 Notice on the Issuance of the ‘Several Measures to Support the Establishment of High-Level Projects by Foreig… Shanghai Municipal Commission of Science and Technology |
| 2026-06-03 | 《药品生产许可证》注销名单（共计1家）序号企业名称许可证编号社会信用代码法定代表人企业负责人质量负责人生产地址和生产范围 Document · Hebei Provincial People's Government |
| 2026-06-02 | 关于报送2026年度生物医药工程高、中级专业技术资格评审申报材料的通知（苏药监人〔2026〕30号） notice · Jiangsu Provincial Bureau of Drug Administration |
| 2026-05-31 | 市人民政府办公厅关于印发武汉市支持生物医药产业创新发展若干措施的通知 Notice from the General Office of the Municipal People’s Government on the Issuance of Several Measures to Su… General Office of the Wuhan Municipal People's Government |
| 2026-05-28 | 省药品监督管理局关于开展全省无菌药品生产质量安全提升行动的通知（鄂药监函〔2026〕51号 ） notice · Hubei Provincial Bureau of Drug Administration |
| 2026-05-11 | 北京市商务局关于印发《推进医药健康产业发展促进药械产品进口工作方案》的通知 Notice from the Beijing Municipal Bureau of Commerce on the Issuance of the ‘Work Plan for Promoting the Deve… Beijing Municipal Bureau of Commerce |
| Measure | Group | Found | checked precision |
|---|---|---|---|
| Capital grant | Fiscal and financial support | 46 | 70% |
| Tax relief | Fiscal and financial support | 16 | 80% |
| Local registration condition | Localisation conditions | 9 | 60% |
| Local production condition | Localisation conditions | 8 | 20% |
| Credit guarantee | Fiscal and financial support | 6 | 90% |
| Interest subsidy | Fiscal and financial support | 5 | 90% |
| First-of-a-kind support | Fiscal and financial support | 3 | 100% |
| Procurement preference | Public procurement | 3 | 40% |
| Import duty relief on inputs | Trade and foreign investment | 2 | not checked |
| Local content condition | Localisation conditions | 2 | 30% |
Precision from the Data page: samples of ten, checked by the AI assistant; a human-coded sample is still to come.
| Provision | How | Disadvantages |
|---|---|---|
| “申请单位应为本市注册的生物医药企业（研发机构），且为报关单实际收货人或者消费使用单位。”
北京市药品监督管理局等单位关于印发《北京市生物医药研发用物品进口工作方案》的通知 京药监发〔2026〕147号 · 2026-07-30 |
Local registration / tax | other regions |
| “强化从土地获取、开工建设到生产变更申报、上市流通销售等全方位支持，提高进口转本地生产项目落地效率。”
关于印发《关于支持生物医药外资企业高能级项目落地的若干措施》的通知 沪科合〔2026〕5号 · 2026-06-23 |
Local production requirement | imports, other regions |
| “研究制定医疗器械注册证跨省转移的落地政策与服务流程，对转入本市注册的Ⅱ类医疗器械，优化申报资料及核查程序。”
北京市商务局关于印发《推进医药健康产业发展促进药械产品进口工作方案》的通知 京商函字〔2026〕376号 · 2026-05-11 |
Local registration / tax | other regions |
| “对境内隶属于同一集团或者具有同一实际控制人的企业，将已获准境内注册且在有效期内的第二类医疗器械注册证迁入我省注册且自行生产的，若产品无实质改变，符合现行法律法规及强制性标准，完成工艺验证且检验合格的，在申报产品注册时，可使用原产品注册时的综述资料、非临床资料（安全和性能基本原则清单、产品技术要求及…”
省药品监督管理局关于印发 《关于支持医疗器械产业高质量发展服务支点建设的若干措施》的通知 鄂药监发〔2026〕1号 · 2026-02-28 |
Local registration / tax | other regions |
| “对在研重点药品、进口转本地生产药品优先进行注册抽样和检查，同步开展注册核查与生产质量管理规范符合性检查。”
上海市人民政府办公厅关于印发《上海市全面深化药品医疗器械监管改革促进医药产业高质量发展的若干措施》的通知 · 2025-10-23 |
Local production requirement | imports, other regions |
| “支持天津市生物医药领域重点高校、医疗机构、科研院所等在高新区布局建设成果转化平台，支持拥有自主知识产权项目团队在区内发展，给予最高50万元资金支持。”
天津滨海高新区关于促进生物医药产业高质量发展的鼓励办法（修订版） · 2025-09-24 |
Ownership, own-brand or own-IP test | foreign-owned firms |
Keyword and model screens: leads to check against the document, not findings. Newest first, one per document.
| No in-force date in the next 12 months. |
| 2026-12-31 | 北京市药品监督管理局等单位关于印发《北京市生物医药研发用物品进口工作方案》的通知 北京市药品监督管理局 北京市经济和信息化局;北京市科学技术委员会、中关村科技园… |
| 2026-12-31 | 关于开展生物医药人体临床试验责任保险、产品责任保险工作的通知 Shanghai Municipal Commission of Scienc… |
| 2026-12-31 | 关于印发《宁波市加快推进生物医药产业发展若干意见》的通知 Ningbo Municipal Bureau of Economy and … |
| 2026-12-31 | 福建省财政厅 福建省工业和信息化厅 福建省科学技术厅 福建省农业农村厅关于印发《福建省省级生物医药产业发展专项资金管理办法》的通知 Fujian Provincial Department of Finance |
| 2026-12-31 | 厦门市人民政府关于印发加快推进生物医药产业高质量发展若干措施的通知 Xiamen Municipal People's Government |
| 2027-09-28 | 福建省科学技术厅 福建省药品监督管理局关于印发《福建省创新药物研发奖励资金补助实施办法》的通知 Fujian Provincial Department of Science… |
| 2027-10-30 | 上海市人民政府办公厅关于印发《上海市加快打造全球生物医药研发经济和产业化高地的若干政策措施》的通知 Shanghai Municipal Commission of Scienc… |
| Firm | Ownership | Listings |
|---|---|---|
| No firm lists in these documents. | ||
No listed group in this sector with HKEX grants extracted.
140 documents whose title matches 生物医药|医药产业|医药工业|创新药|原料药|生物药|医药制造|药品(?:研发|生产|创新), plus 80 in the topic tree pharma; 204 together. Goods: HS 3002, 3004. Measures and preference provisions are screen output; open each document for the clause.